{
  "id": 15753344,
  "title": "Autoimmune disease risk may differ by menopausal hormone therapy formulation",
  "url": "https://urgent.news/2026/10/20/autoimmune-disease-risk-may-differ-by-menopausal-hormone-therapy",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-20T14:20:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-autoimmune-disease-differ-menopausal-hormone.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Progestogen, when used in hormone therapy, is recognized for its benefits in protecting the uterus. A new study suggests that its addition limits the increased risk of composite autoimmune disease associated with estrogen-only therapy. Results of the study were presented at the 2026 Annual Meeting of The Menopause Society in San Diego, Oct. 20–24, 2026.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}